Zhejiang Huahai Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ENTECAVIR USP, with a corresponding US DMF Number 27848.
Remarkably, this DMF maintains an Active status since its submission on January 07, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 21, 2014, and payment made on October 14, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II